Europe tests Japanese drug against Hanta virus
The European Union has sent shipments of an experimental antiviral drug against the "Hanta" virus to France, Spain, and the Netherlands to support efforts to contain the disease and treat difficult cases. This came as a donation from the Japanese company Fujifilm. The drug "Favipiravir" is among the current options, used in clinical trials or under "compassionate use" protocols, with the decision to administer it remaining at the discretion of the respective countries based on individual medical assessments. The donation was coordinated with Japanese authorities and the European Union, along with initiating procedures to purchase additional quantities in anticipation of rising infection rates.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)